Irinotecan Hydrochloride 50742-0402-05

Package NDC

50742-0402-05

Manufacturer: Ingenus Pharmaceuticals, Llc
Dosage Form: Injection
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: June 5, 2017
Listing Expires: December 31, 2026
Application: ANDA206935

Need to source Irinotecan Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Irinotecan Hydrochloride	100 mg/5mL

Drug Class

Topoisomerase Inhibitor [EPC]Topoisomerase Inhibitors [MoA]

Selected Package

50742-0402-05Selected

1 VIAL, GLASS in 1 CARTON (50742-402-05) / 5 mL in 1 VIAL, GLASS